Skip to main content
Premium Trial:

Request an Annual Quote

An Image Here and There …

An Ohio State University researcher has been sanctioned by the Office of Research Integrity for falsifying and fabricating data included in National Institutes of Health grants and in research papers, reports Retraction Watch. Terry Elton, a pharmacology professor at Ohio State, studies microRNA expression and how miRNAs affect disease, especially cardiovascular disease and Down syndrome.

The investigations conducted by OSU and ORI found that Elton falsified and/or fabricated dozens of Western blots included in a number of grants and papers, and concluded that six articles should be retracted — one of which already has been, Retraction Watch notes.

Elton has entered into a three-year voluntary exclusion agreement, in which he agreed to "exclude himself from any contracting or subcontracting with any agency of the United States Government and from eligibility or involvement in nonprocurement programs of the United States Government … [and] exclude himself voluntarily from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.